Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-08-05 Sale(A) | 2020-08-10 4:03 pm | Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec | 13,374 | $20 | $267,480 | 147,125 (Direct) | View |
| 2020-08-05 Sale | 2020-08-07 5:44 pm | Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec | 13,274 | $20 | $265,480 | 147,225 (Direct) | View |
| 2020-08-03 Sale | 2020-08-05 4:51 pm | Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec | 6,626 | $20 | $132,530 | 304,074 (Direct) | View |
| 2019-06-07 Purchase(A) | 2020-02-24 4:56 pm | Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec | 15,125 | $7.8964 | $119,433 | 17,125 (Direct) | View |
| 2019-06-06 Purchase | 2019-06-10 6:16 pm | Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec | 16,938 | $7.832 | $132,658 | 16,938 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-06 Option Award | 2024-03-08 4:00 pm | N/A 2034-03-05 | Cue Biopharma Inc. | CUE | Sandercock Colin SVP, GENERAL COUNSEL | 175,000 | $0 | 175,000 (Direct) | View |
| 2023-07-21 Option Award | 2023-07-25 12:27 pm | N/A 2033-07-20 | Cue Biopharma Inc. | CUE | Sandercock Colin SVP, GENERAL COUNSEL | 75,000 | $0 | 75,000 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 5:00 pm | N/A 2033-02-15 | Cue Biopharma Inc. | CUE | Sandercock Colin SVP, GENERAL COUNSEL | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-02-09 Option Award | 2022-03-29 4:13 pm | N/A 2032-02-08 | Cue Biopharma Inc. | CUE | Sandercock Colin SVP, GENERAL COUNSEL | 76,667 | $0 | 76,667 (Direct) | View |
| 2021-02-10 Option Award | 2021-02-12 5:43 pm | N/A 2031-02-09 | Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec | 50,000 | $0 | 50,000 (Direct) | View |
| 2020-08-05 Exercise(A) | 2020-08-10 4:03 pm | N/A N/A | Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec | 13,374 | $7.5 | 147,125 (Direct) | View |
| 2020-08-05 Exercise(A) | 2020-08-10 4:03 pm | N/A 2024-12-27 | Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec | 13,374 | $0 | 147,125 (Direct) | View |
| 2020-08-05 Exercise | 2020-08-07 5:44 pm | N/A N/A | Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec | 13,274 | $7.5 | 147,225 (Direct) | View |
| 2020-08-05 Exercise | 2020-08-07 5:44 pm | N/A 2024-12-27 | Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec | 13,274 | $0 | 147,225 (Direct) | View |
| 2020-08-03 Exercise | 2020-08-05 4:51 pm | N/A N/A | Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec | 6,626 | $7.5 | 304,074 (Direct) | View |
| 2020-08-03 Exercise | 2020-08-05 4:51 pm | N/A 2024-12-27 | Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec | 6,626 | $0 | 304,074 (Direct) | View |
| 2020-02-05 Option Award | 2020-02-12 4:53 pm | N/A 2030-02-05 | Cue Biopharma Inc. | CUE | Sandercock Colin SVP, General Counsel and Sec | 20,000 | $0 | 20,000 (Direct) | View |